22:46 , Jul 24, 2019 |  BC Extra  |  Financial News

New investors bring key connections to Freenome’s machine learning diagnostics

A host of first-time investors joined a $160 million series B round for machine learning-powered cancer diagnostics company Freenome, bringing a diverse set of connections as the company maps out its go-to-market strategy and goals...
19:49 , Jun 7, 2019 |  BioCentury  |  Emerging Company Profile

insitro: machine learning with designated data

Just 12 months after announcing the launch of insitro, AI veteran and CEO Daphne Koller has led the drug discovery and machine learning company to a series A round of over $100 million and a...
12:21 , Apr 16, 2019 |  BC Extra  |  Company News

With insitro deal, Gilead turns to machine learning to unlock new NASH targets

Not yet content with the trio of clinical programs in its pipeline, Gilead has struck its third NASH deal this year, this time banking on machine learning company insitro to develop disease models and discover...
19:23 , Mar 8, 2019 |  BC Week In Review  |  Financial News

Erasca extends series A by $22M

Erasca raised additional funds to enable compound in-licensing and accelerate development of its Oncology Pattern Recognition Algorithm (OPRA) for discovering cancer cures. Erasca Inc. (San Diego, Calif.) raised $22 million in a series A extension,...
14:20 , Jul 12, 2018 |  BC Innovations  |  Emerging Company Profile

Gene control goals

By mapping all of the signaling pathways and transcription factors that control the expression of every gene in a cell type of interest, Camp4 Therapeutics Corp. is betting its machine learning-based platform will be able...
19:31 , Jun 1, 2018 |  BC Week In Review  |  Financial News

CAMP4 Therapeutics launches with $30M series A

CAMP4 Therapeutics Corp. (Cambridge, Mass.) launched on May 31 with an untranched $30 million series A round led by new investor Andreessen Horowitz. Existing investors The Kraft Group and Polaris Partners also participated. A CAMP4...
12:31 , May 31, 2018 |  BC Extra  |  Financial News

CAMP4 Therapeutics launches with $30M series A

CAMP4 Therapeutics Corp. (Cambridge, Mass.) launched with an untranched $30 million series A round led by new investor Andreessen Horowitz. Existing investors The Kraft Group and Polaris Partners also participated. A CAMP4 spokesperson told BioCentury...
16:26 , May 4, 2018 |  BC Week In Review  |  Company News

Koller turns AI on drug discovery with newco insitro

Former Calico Life Sciences LLC Chief Computing Officer Daphne Koller has set her sights on modernizing the drug discovery process through her new venture, insitro Inc. (Menlo Park, Calif.). The company has secured undisclosed capital...
20:46 , May 2, 2018 |  BC Extra  |  Company News

Koller turns AI on drug discovery with newco insitro

Former Calico Life Sciences LLC Chief Computing Officer Daphne Koller has set her sights on modernizing the drug discovery process through her new venture, insitro Inc. (Menlo Park, Calif.). The company has secured undisclosed capital...
16:37 , Mar 23, 2018 |  BC Week In Review  |  Financial News

AI company twoXAR raises $10M series A

AI company twoXAR Inc. (Palo Alto, Calif.) raised $10 million on March 19 in an untranched series A round led by new investor SoftBank Ventures. Existing investor Andreessen Horowitz Bio Fund and new investor OS...